These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32842599)

  • 1. Machine Learning Facilitates Hotspot Classification in PSMA-PET/CT with Nuclear Medicine Specialist Accuracy.
    Moazemi S; Khurshid Z; Erle A; Lütje S; Essler M; Schultz T; Bundschuh RA
    Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32842599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision-support for treatment with
    Moazemi S; Erle A; Khurshid Z; Lütje S; Muders M; Essler M; Schultz T; Bundschuh RA
    Ann Transl Med; 2021 May; 9(9):818. PubMed ID: 34268431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating a Machine Learning Tool for the Classification of Pathological Uptake in Whole-Body PSMA-PET-CT Scans.
    Erle A; Moazemi S; Lütje S; Essler M; Schultz T; Bundschuh RA
    Tomography; 2021 Jul; 7(3):301-312. PubMed ID: 34449727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of hybrid
    Janssen JC; Meißner S; Woythal N; Prasad V; Brenner W; Diederichs G; Hamm B; Makowski MR
    Eur Radiol; 2018 Feb; 28(2):610-619. PubMed ID: 28779400
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallium-68-prostate-specific membrane antigen (
    van Leeuwen PJ; Donswijk M; Nandurkar R; Stricker P; Ho B; Heijmink S; Wit EMK; Tillier C; van Muilenkom E; Nguyen Q; van der Poel HG; Emmett L
    BJU Int; 2019 Jul; 124(1):62-68. PubMed ID: 30074667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, Predictive Factors, and Prediction Nomograms for
    Rauscher I; Düwel C; Haller B; Rischpler C; Heck MM; Gschwend JE; Schwaiger M; Maurer T; Eiber M
    Eur Urol; 2018 May; 73(5):656-661. PubMed ID: 29358059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparative Study of
    Gupta M; Choudhury PS; Hazarika D; Rawal S
    World J Nucl Med; 2017; 16(3):186-191. PubMed ID: 28670175
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Oliveira JM; Gomes C; Faria DB; Vieira TS; Silva FA; Vale J; Pimentel FL
    World J Nucl Med; 2017; 16(1):3-7. PubMed ID: 28217012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of
    Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
    BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver agreement of [
    Derwael C; Lavergne O; Lovinfosse P; Nechifor V; Salvé M; Waltregny D; Hustinx R; Withofs N
    EJNMMI Res; 2020 Feb; 10(1):15. PubMed ID: 32112230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients.
    Natarajan A; Agrawal A; Murthy V; Bakshi G; Joshi A; Purandare N; Shah S; Puranik A; Rangarajan V
    World J Nucl Med; 2019; 18(3):244-250. PubMed ID: 31516367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer.
    Maurer T; Gschwend JE; Rauscher I; Souvatzoglou M; Haller B; Weirich G; Wester HJ; Heck M; Kübler H; Beer AJ; Schwaiger M; Eiber M
    J Urol; 2016 May; 195(5):1436-1443. PubMed ID: 26682756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with
    Moazemi S; Erle A; Lütje S; Gaertner FC; Essler M; Bundschuh RA
    Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33525456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of [
    Frenzel T; Tienken M; Abel M; Berliner C; Klutmann S; Beyersdorff D; Schwarz R; Krüll A; Bannas P
    Strahlenther Onkol; 2018 Jul; 194(7):646-654. PubMed ID: 29572670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Performance of [
    Paymani Z; Rohringer T; Vali R; Loidl W; Alemohammad N; Geinitz H; Langsteger W; Beheshti M
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of
    Albisinni S; Artigas C; Aoun F; Biaou I; Grosman J; Gil T; Hawaux E; Limani K; Otte FX; Peltier A; Sideris S; Sirtaine N; Flamen P; van Velthoven R
    BJU Int; 2017 Aug; 120(2):197-203. PubMed ID: 27981732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.
    Luiting HB; van Leeuwen PJ; Busstra MB; Brabander T; van der Poel HG; Donswijk ML; Vis AN; Emmett L; Stricker PD; Roobol MJ
    BJU Int; 2020 Feb; 125(2):206-214. PubMed ID: 31680398
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Dyrberg E; Hendel HW; Huynh THV; Klausen TW; Løgager VB; Madsen C; Pedersen EM; Pedersen M; Thomsen HS
    Eur Radiol; 2019 Mar; 29(3):1221-1230. PubMed ID: 30132104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.